News

Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer’s disease

Congratulations to:

• Samir Yahiaoui^a,
• Katia Hamidouche^b,
• Céline Ballandonne^a,
• Audrey Davis^a,
• Jana Sopkova de Oliveira Santos^a,
• Thomas Freret^b,
• Michel Boulouard^b,
• Christophe Rochais^{a, ,} ,
• Patrick Dallemagne^{a, ,}

for publishing a new article in European Journal of Medicinal Chemistry using our actimeters.

• ^a Normandie Université, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), F-14032, Caen, France
• ^b Normandie Université, UNICAEN, GMPc (Groupe Mémoire et Plasticité comportementale), F-14032, Caen, France

Received 1 April 2016, Revised 20 May 2016, Accepted 21 May 2016, Available online 26 May 2016